Product Information

DARIFENACIN ER 15 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.4819 per EA under NDC 16571076809. Its NADAC has been published 233 times since Jun 1, 2022.

FDA first approved this application on Sep 19, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DARIFENACIN ER 15 MG TABLET

Darifenacin
$0.4819per EA

Strength

15 mg/1

NDC

16571076809

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

DARIFENACIN HYDROBROMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA206743

FDA Approved

9/19/2016

TE Code

AB

On Market Since

9/19/2016

Pharmacological Classes

Cholinergic Muscarinic Antagonist
Cholinergic Muscarinic Antagonists

Price Statistics

The NADAC for DARIFENACIN ER 15 MG TABLET has been published 233 times since Jun 1, 2022, and over the history we have for it it has declined 81.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4819 per EA
All-time high$2.6601 (Jun 15, 2022)
All-time low$0.3150 (Mar 19, 2025)
52-week high$0.4819
52-week low$0.3715
Median price$0.6086
Average price$0.8712
Largest weekly change+85.9% (Aug 21, 2024)
Weeks tracked233
Tracking sinceJun 1, 2022

Price History

1W

0.0%

1M

+11.5%

3M

+21.3%

6M

+13.5%

1Y

+37.8%

3Y

-68.7%

5Y

N/A

All

-81.9%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DARIFENACIN ER 15 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DARIFENACIN ER 15 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.4819 per EA (NDC 16571076809), effective Nov 11, 2026.

How has the price of DARIFENACIN ER 15 MG TABLET changed over time?

Over the history we have for it, the NADAC for DARIFENACIN ER 15 MG TABLET has declined 81.9%. It has been tracked across 233 weekly CMS publications since Jun 1, 2022.

What are the highest and lowest recorded NADAC prices for DARIFENACIN ER 15 MG TABLET?

Since Jun 1, 2022, the NADAC for DARIFENACIN ER 15 MG TABLET has ranged from a low of $0.3150 (Mar 19, 2025) to a high of $2.6601 (Jun 15, 2022), with a median of $0.6086 per EA.

Are there cheaper alternatives to DARIFENACIN ER 15 MG TABLET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DARIFENACIN ER 15 MG TABLET, is $0.4394 per EA — about 9% below DARIFENACIN ER 15 MG TABLET.

Who manufactures DARIFENACIN ER 15 MG TABLET?

DARIFENACIN ER 15 MG TABLET (NDC 16571076809) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.